Industry Experts

A biotech veteran with 25+ years of experience leading drug development in gene and cell therapy, genome editing, and targeted biologics. She has taken multiple programs from early research to the clinic, serving as lead on seven FDA INDs and overseeing development across immunology, oncology, hematology, neurology, rare diseases, and cardiology. She’s built and led cross-functional teams, secured over $250M in public and private funding, and managed key partnerships with NIH, DoD, BARDA, and research collaborators.